Azobenzenes
eMolecules ChemScene / 26-Difluoroterephthalonitrile / 100mg / 599129682 / CS-0088971 / 0.000 / 510772-86-8 / MFCD18806059 / 164.115 / C8H2F2N2
ChemScene / 26-Difluoroterephthalonitrile / 100mg / 599129682 / CS-0088971 / 0.000 / 510772-86-8 / MFCD18806059 / 164.115 / C8H2F2N2
Medchemexpress LLC Sudoxicam 50mg | 34042-85-8 | 50MG
Sudoxicam is a reversible and orally active COX antagonist and a non-steroidal anti-inflammatory drug (NSAID) from the enol-carboxamide class Sudoxicam has potent anti-inflammatory anti-edema and antipyretic activity[1 [2 [3
Medchemexpress LLC 4-hydroxytolbutamide | 5719-85-7 | MFCD00144466 | 99.7% | 286.35 g/mol | C12H18N2O4S | 5 MG
4-Hydroxytolbutamide is a hydroxylated metabolite of the sulfonylurea tolbutamide, used as a reference compound in studies of drug metabolism and cytochrome P450 enzyme activity. It is employed to investigate biotransformation pathways mediated by CYP2C8 and CYP2C9.
- Suitable as a reference standard for CYP2C8 and CYP2C9 metabolism studies.
- High purity (>99%) for analytical and bioanalytical applications.
- Solid powder form for ease of handling and storage.
- Stored at -20°C in powder; in solvent store at -80°C for long-term stability.
- Chemical formula C12H18N2O4S; molecular weight 286.35 g/mol.
eMolecules ChemScene / (5-Methyl-6-morpholinopyridin-3-yl)boronic acid / 100mg / 712787972 / CS-0338831 / 0.000 / 1191062-85-7 / MFCD10566507 / 222.050 / C10H15BN2O3
ChemScene / (5-Methyl-6-morpholinopyridin-3-yl)boronic acid / 100mg / 712787972 / CS-0338831 / 0.000 / 1191062-85-7 / MFCD10566507 / 222.050 / C10H15BN2O3
Medchemexpress LLC Atuliflapon (AZD5718) | 2041075-86-7 | 99.0% | 50 MG
Atuliflapon (AZD5718) is a reversible inhibitor of 5-lipoxygenase activating protein (FLAP) developed for investigation of leukotriene-mediated inflammation and cardiovascular indications. It shows nanomolar potency against FLAP and has been evaluated in first-in-human and Phase 2a clinical studies. The compound is provided as a solid research sample for in vitro and translational research.
- Reversible FLAP inhibitor with FLAP IC50 ≈ 2 nM.
- Inhibits LTB4 production in human whole blood (IC50 ≈ 39 nM).
- High purity research sample (98.97%).
- Molecular weight 446.50 g/mol; chemical formula C24H26N6O3.
- Suitable for in vitro and translational/clinical research; not for clinical use.
- Pack size typically 50 mg solid sample.
![Medchemexpress LLC 7-fluoro-6-methoxy-4-[6-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]quinol | 2248154-85-8 | MFCD32859311 | 99.4% | C26H30FN7O | 10MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000260000.png-250.jpg)
Medchemexpress LLC 7-fluoro-6-methoxy-4-[6-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]quinol | 2248154-85-8 | MFCD32859311 | 99.4% | C26H30FN7O | 10MG
KER047 (ALK2-IN-4) is a potent small-molecule inhibitor of activin receptor-like kinase-2 (ALK2) intended for research use in the study of ALK2-mediated signaling and metabolic disorders such as fibrodysplasia ossificans progressiva (FOP). The compound is provided in solid and solution formats for in vitro and preclinical investigations.
- Potent ALK2 inhibitor with demonstrated activity in research assays.
- Suitable for research into metabolic disease models, including FOP.
- High purity (99.4%) for reproducible experimental results.
- Available as solid powder and 10 mM solutions in DMSO for flexible dosing.
- Chemical formula C26H30FN7O and molecular weight 475.56 g/mol.
- Stable storage recommendations: powder at -20°C or 4°C; in solvent at -80°C or -20°C.
eMolecules AstaTech / 1-(AMINOMETHYL)CYCLOHEXAN-1-OL HYDROCHLORIDE / 0.25g / 718057444 / D75568 / 98.000 / 19968-85-5 / MFCD00003859 / 165.660 / C7H16ClNO
AstaTech / 1-(AMINOMETHYL)CYCLOHEXAN-1-OL HYDROCHLORIDE / 0.25g / 718057444 / D75568 / 98.000 / 19968-85-5 / MFCD00003859 / 165.660 / C7H16ClNO
![eMolecules AstaTech / 14-DIAZASPIRO[5.5]UNDECAN-5-ONE / 1g / 718056409 / AT28656 / 95.000 / 86047-86-1 / MFCD07373481 / 168.240 / C9H16N2O](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502465028.JPG-250.jpg)
eMolecules AstaTech / 14-DIAZASPIRO[5.5]UNDECAN-5-ONE / 1g / 718056409 / AT28656 / 95.000 / 86047-86-1 / MFCD07373481 / 168.240 / C9H16N2O
AstaTech / 14-DIAZASPIRO[5.5]UNDECAN-5-ONE / 1g / 718056409 / AT28656 / 95.000 / 86047-86-1 / MFCD07373481 / 168.240 / C9H16N2O
eMolecules AstaTech / 2-OXOCYCLOHEXANECARBOXYLIC ACID SODIUM SALT / 0.25g / 296378971 / F11699 / 95.000 / 75265-85-9 / MFCD30530423 / 164.136 / C7H9NaO3
AstaTech / 2-OXOCYCLOHEXANECARBOXYLIC ACID SODIUM SALT / 0.25g / 296378971 / F11699 / 95.000 / 75265-85-9 / MFCD30530423 / 164.136 / C7H9NaO3
eMolecules Medchem Express / Calpain-2-IN-1 / 5mg / 769193475 / HY-145155 / / 144231-85-6 / MFCD28400876 / 527.618 / C28H37N3O7
Medchem Express / Calpain-2-IN-1 / 5mg / 769193475 / HY-145155 / / 144231-85-6 / MFCD28400876 / 527.618 / C28H37N3O7
Medchemexpress LLC Kansuinine A | 57701-86-7 | 99.8% | 730.75 g·mol⁻1 | C37H46O15 | 5 MG
Kansuinine A is a natural diterpenoid research compound that inhibits IL-6-induced STAT3 activation and has reported antiviral and anticancer activity. It is supplied as a high-purity solid with documented solubility and storage profiles for in vitro experimentation and dosing accuracy.
- Inhibits IL-6-induced STAT3 activation
- Reported antiviral and anticancer activity
- High purity (≈99.8%) suitable for research applications
- Supplied as a white to off-white solid with high solubility in DMSO
- Stable when stored as powder at -20 °C and in solvent under recommended conditions
- Molecular weight 730.75 g·mol⁻1 and formula C37H46O15 for accurate dosing
Medchemexpress LLC N-cycloheptyl-6,7-dimethoxy-2-(4-piperidin-1-ylpiperidin-1-yl)quinazolin-4-amine | 864289-85-0 | 100.0% | 467.65 g/mol | C27H41N5O2 | 50 MG
C-021 is a small-molecule antagonist of CC chemokine receptor 4 (CCR4) developed for research applications; it blocks CCR4-mediated signaling and functional chemotaxis, with low-nanomolar activity in binding and cell-based assays.
- Potent CCR4 antagonist with low-nanomolar binding activity.
- Prevents CCL22-derived [35S]GTPγS binding to CCR4 (IC50 18 nM) and inhibits functional chemotaxis (human 140 nM, mouse 39 nM).
- Molecular formula C27H41N5O2; molecular weight 467.65 g/mol.
- High purity (~99.95%).
- Solid form with recommended storage: powder -20°C (long term) or 4°C (short term); in solvent store at -80°C.
- Intended for research use only; not for human use.